Literature DB >> 3882995

A deletion mutation in the 5' part of the pol gene of Moloney murine leukemia virus blocks proteolytic processing of the gag and pol polyproteins.

S Crawford, S P Goff.   

Abstract

Deletion mutations in the 5' part of the pol gene of Moloney murine leukemia virus were generated by restriction enzyme site-directed mutagenesis of cloned proviral DNA. DNA sequence analysis indicated that one such deletion was localized entirely within the 5' part of the pol gene, did not affect the region encoding reverse transcriptase, and preserved the translational reading frame downstream of the mutation. The major viral precursor polyproteins (Pr65gag, Pr200gag-pol, and gPr80env) were synthesized at wild-type levels in cell lines carrying the mutant genome. These cell lines assembled and released wild-type levels of virion particles into the medium. Cleavage of both Pr65gag and Pr200gag-pol precursors to the mature proteins was completely blocked in the mutant virions. Surprisingly, these virions contained high levels of active reverse transcriptase; examination of the endogenous reverse transcription products synthesized by the mutant virions revealed normal amounts of minus-strand strong-stop DNA, indicating that the RNA genome was packaged and that reverse transcription in detergent-permeabilized virions was not significantly impaired. Processing of gPr80env to gP70env and P15E was not affected by the mutation, but cleavage of P15E to P12E was not observed. The mutant particles were poorly infectious; analysis indicated that infection was blocked at an early stage. The data are consistent with the idea that the 5' part of the pol gene encodes a protease directly responsible for processing Pr65gag, and possibly Pr200gag-pol, to the structural virion proteins. It appears that cleavage of the gag gene product is not required for budding and release of virions and that complete processing of the pol gene product to the mature form of reverse transcriptase is not required for its functional activation.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3882995      PMCID: PMC254725     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  57 in total

1.  Amino- and carboxyl-terminal amino acid sequences of proteins coded by gag gene of murine leukemia virus.

Authors:  S Oroszlan; L E Henderson; J R Stephenson; T D Copeland; C W Long; J N Ihle; R V Gilden
Journal:  Proc Natl Acad Sci U S A       Date:  1978-03       Impact factor: 11.205

2.  Translation of MuLV and MSV RNAs in nuclease-treated reticulocyte extracts: enhancement of the gag-pol polypeptide with yeast suppressor tRNA.

Authors:  L Philipson; P Andersson; U Olshevsky; R Weinberg; D Baltimore; R Gesteland
Journal:  Cell       Date:  1978-01       Impact factor: 41.582

3.  Selective extraction of polyoma DNA from infected mouse cell cultures.

Authors:  B Hirt
Journal:  J Mol Biol       Date:  1967-06-14       Impact factor: 5.469

4.  Calcium-dependent bacteriophage DNA infection.

Authors:  M Mandel; A Higa
Journal:  J Mol Biol       Date:  1970-10-14       Impact factor: 5.469

5.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

6.  Impaired processing of precursor polypeptides of temperature-sensitive mutants of Rauscher murine leukemia virus.

Authors:  W J van de Ven; D van Zaane; C Onnekink; H P Bloemers
Journal:  J Virol       Date:  1978-02       Impact factor: 5.103

Review 7.  The biosynthesis of oncovirus proteins.

Authors:  R N Eisenman; V M Vogt
Journal:  Biochim Biophys Acta       Date:  1978-04-06

8.  Cell-free synthesis of a precursor polyprotein containing both gag and pol gene products by Rauscher murine leukemia virus 35S RNA.

Authors:  E C Murphy; J J Kopchick; K F Watson; R B Arlinghaus
Journal:  Cell       Date:  1978-02       Impact factor: 41.582

9.  Plaque assay techniques for murine leukemia viruses.

Authors:  W P Rowe; W E Pugh; J W Hartley
Journal:  Virology       Date:  1970-12       Impact factor: 3.616

10.  Properties of a P70 proteolytic factor of murine leukemia viruses.

Authors:  Y Yoshinaka; R B Luftig
Journal:  Cell       Date:  1977-11       Impact factor: 41.582

View more
  113 in total

1.  The role of the membrane-spanning domain sequence in glycoprotein-mediated membrane fusion.

Authors:  G M Taylor; D A Sanders
Journal:  Mol Biol Cell       Date:  1999-09       Impact factor: 4.138

2.  The human immunodeficiency virus type 1 Gag polyprotein has nucleic acid chaperone activity: possible role in dimerization of genomic RNA and placement of tRNA on the primer binding site.

Authors:  Y X Feng; S Campbell; D Harvin; B Ehresmann; C Ehresmann; A Rein
Journal:  J Virol       Date:  1999-05       Impact factor: 5.103

3.  Somatic cell mutants resistant to retrovirus replication: intracellular blocks during the early stages of infection.

Authors:  G Gao; S P Goff
Journal:  Mol Biol Cell       Date:  1999-06       Impact factor: 4.138

4.  Viral DNA carried by human immunodeficiency virus type 1 virions.

Authors:  F Lori; F di Marzo Veronese; A L de Vico; P Lusso; M S Reitz; R C Gallo
Journal:  J Virol       Date:  1992-08       Impact factor: 5.103

5.  Mutational analysis of the gag-pol junction of Moloney murine leukemia virus: requirements for expression of the gag-pol fusion protein.

Authors:  K M Felsenstein; S P Goff
Journal:  J Virol       Date:  1992-11       Impact factor: 5.103

6.  Reversal by dithiothreitol treatment of the block in murine leukemia virus maturation induced by disulfide cross-linking.

Authors:  Stephen Campbell; Masamichi Oshima; Jane Mirro; Kunio Nagashima; Alan Rein
Journal:  J Virol       Date:  2002-10       Impact factor: 5.103

7.  The PPPY motif of human T-cell leukemia virus type 1 Gag protein is required early in the budding process.

Authors:  Isabelle Le Blanc; Marie-Christine Prévost; Marie-Christine Dokhélar; Arielle R Rosenberg
Journal:  J Virol       Date:  2002-10       Impact factor: 5.103

8.  Matrix protein of Akv murine leukemia virus: genetic mapping of regions essential for particle formation.

Authors:  E C Jørgensen; F S Pedersen; P Jørgensen
Journal:  J Virol       Date:  1992-07       Impact factor: 5.103

9.  Incorporation of excess wild-type and mutant tRNA(3Lys) into human immunodeficiency virus type 1.

Authors:  Y Huang; J Mak; Q Cao; Z Li; M A Wainberg; L Kleiman
Journal:  J Virol       Date:  1994-12       Impact factor: 5.103

10.  Characterization of amplified intracisternal A-particle elements encoding integrase.

Authors:  K K Lueders; Z Grossman; J W Fewell
Journal:  Nucleic Acids Res       Date:  1989-11-25       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.